Arbutus Presents New Data on AB-729, AB-836 and AB-101 at
AB-729, our RNAi therapeutic, provided robust and comparable HBsAg declines in both HBeAg+ and HBeAg- patients...
William Collier Fung Yuen Arbutus Biopharma Corporation Nasdaq Division Of Gastroenterology Deputy Head Of Department University Of Hong Kong
Source: globenewswire.com